Skip to search.
 FTSE 100 Up 0.26%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
12.17 Down 0.28(2.25%) 22 May 21:00
Add to Portfolio
Prev Close:12.45
Open:12.47
Bid:10.96 x 100
Ask:N/A
1y Target Est:22.00
Beta:2.58
Earnings Date:21 Jul - 27 Jul (Est.)
Day's Range:12.16 - 12.57
52wk Range:9.39 - 19.25
Volume:754,106
Avg Vol (3m):810,625
Market Cap:846.83m
P/E (ttm):N/A
EPS (ttm):-0.35
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGMODown 2.25%846.83m
AMGNDown 0.16%124.37b
LLYUp 0.04%78.68b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Jun-15) :-0.13
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for unmet medical needs in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback